Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000088

Drug Information
SynonymsBetimol; NCGC00016038-01; (2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol; Timacar; C07141; MK-950; AB00513729; Istalol; SAM002564238; Tenopt; Prestwick3_000948; Prestwick1_000948; DB08625; Timoptic-XE; Tim-AK; Timololum; (-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole; Proflax; S(-)-Timolol maleate; Optimol; TIM; Prestwick2_000948; HSDB 6533; Tocris-0649; LS-122231; Timolol [USAN]; Timolol (INN); Lopac-T-6394; BPBio1_001008; HMS2089I11; 26921-17-5 (maleate (1:1) salt); Timoptol; Prestwick0_000948; NCGC00022033-04; CHEMBL499; Timolol GFS; BSPBio_000916; L-714,465; Blocadren; Timopic; Oprea1_640981; 26839-75-8; ST072193; NCGC00022033-05; (S)-timolol; DB00373; timolol; Betimol (TN); BRD-K08806317-050-03-6; Phoxal-timolol; NCGC00016798-07; CID33624; Timololum [INN-Latin]; Temserin; NCGC00016798-01; (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol; Apo-Timop; CHEBI:9599; Timolol (TN); NCGC00016038-02; (S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol; Timolol Maleate, (1:1) Salt; 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (2S)-; Timoptic OcuDose; D08600; Lopac0_001189; EINECS 248-032-6; 194288-09-0; (S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol; C13H24N4O3S; UNII-817W3C6175; NCGC00022033-02; (2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol; Aquanil; CAS-26921-17-5; AC1Q59QM; Apo-Timol; BIDD:GT0073; Betim; Novo-Timol; SPBio_003075; 131628-37-0; S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole; CPD001456519; AC1L1PYN; Nu-Timolol; 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-    
Trade NameApo-Timol; Apo-Timop; Gen-Timolol; Nu-Timolol; Phoxal-timolol; PMS-Timolol; Tim-AK; Timoptic; Timoptic-XE; Betimol; Blocadren; Istalol; Timoptic; Timoptic-XE; Timoptic OcuDose.    
CompanyMerck Frosst    
IndicationHigh blood pressureApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnti-Arrhythmia Agents    
CAS NumberCAS 26839-75-8
PubChem Compound IDCID 33624.    
PubChem Substance IDSID 9350.    
SuperDrug ATC IDC07AA06;    
SuperDrug CAS ID026839758;    
TargetBeta adrenergic receptorAntagonist[2][3][4]
Ref 1Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension. Expert Opin Pharmacother. 2009 Aug;10(12):2015-24. To Reference
Ref 2Topical dorzolamide 2%/timolol 0.5% ophthalmic solution: a review of its use in the treatment of glaucoma and ocular hypertension. Drugs Aging. 2006;23(12):977-95. To Reference
Ref 3Blockade of beta-adrenergic receptors prevents amphetamine-induced behavioural sensitization in rats: a putative role of the bed nucleus of the stria terminalis. Int J Neuropsychopharmacol. 2005 Dec;8(4):569-81. Epub 2005 Apr 19. To Reference
Ref 4A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects. Br J Clin Pharmacol. 1997 Mar;43(3):301-8. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543